Company:  OPGEN INC (OPGN)
Form Type:  DEFA14A
Filing Date:  4/25/2022 
CIK:  0001293818 
Address:  9717 KEY WEST AVENUE
SUITE 100
 
City, State, Zip:  ROCKVILLE, Maryland 20850 
Telephone:  240-813-1260 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$0.39  
Change: 
-0.0284 (-6.83%)  
Trade Time: 
Sep 23  
Market Cap: 
$18.70M
Trade OPGN now with

© 2022  
Description of Business
Please refer to the Glossary at the end of this Business section for definitions or descriptions of scientific, diagnostic, healthcare, regulatory, and OpGen-specific terms used in this Annual Report. Overview OpGen, Inc. (the "Company") is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. Along with our subsidiaries, Curetis GmbH and Ares Genetics GmbH, we are developing and commercializing molecular microbiology solutions helping to guide clinicians with more rapid and actionable information about life threatening infections to improve patient outcomes and decrease the spread of infections caused by multidrug-resistant microorganisms, or MDROs.
Register and access this filing in:     
  FORM DEFA14A